Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (939)
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$41.03
Total Value
$83.46K
Shares Held After
221,388
% of Holdings
0.9%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL&CORP SEC
Shares
627
Price
$26.33
Total Value
$16.51K
Shares Held After
20,598
% of Holdings
3.0%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
5,786
Price
$23.19
Total Value
$134.15K
Shares Held After
9,110
% of Holdings
38.8%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
17,000
Price
$96.72
Total Value
$1.64M
Shares Held After
180,209
% of Holdings
8.6%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — Chief Legal Officer and Corporate Secretary
Shares
2,600
Price
$93.46
Total Value
$243.00K
Shares Held After
2,845
% of Holdings
47.8%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — Chief Legal Officer and Corporate Secretary
Shares
2,100
Price
$92.70
Total Value
$194.67K
Shares Held After
5,445
% of Holdings
27.8%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — Chief Legal Officer and Corporate Secretary
Shares
7,228
Price
$91.35
Total Value
$660.28K
Shares Held After
7,545
% of Holdings
48.9%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — Chief Legal Officer and Corporate Secretary
Shares
16,605
Price
$90.35
Total Value
$1.50M
Shares Held After
14,773
% of Holdings
52.9%
Spyre Therapeutics, Inc. (SYRE)
King-Jones Heidy — Chief Legal Officer and Corporate Secretary
Shares
400
Price
$89.24
Total Value
$35.70K
Shares Held After
31,378
% of Holdings
1.3%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
229
Price
$93.57
Total Value
$21.43K
Shares Held After
79,762
% of Holdings
0.3%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
3,071
Price
$92.95
Total Value
$285.45K
Shares Held After
79,991
% of Holdings
3.7%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
2,100
Price
$91.92
Total Value
$193.03K
Shares Held After
83,062
% of Holdings
2.5%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
1,500
Price
$90.27
Total Value
$135.41K
Shares Held After
85,162
% of Holdings
1.7%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
600
Price
$89.07
Total Value
$53.44K
Shares Held After
86,662
% of Holdings
0.7%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
100
Price
$93.91
Total Value
$9.39K
Shares Held After
537,540
% of Holdings
0.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
4,990
Price
$93.37
Total Value
$465.92K
Shares Held After
537,640
% of Holdings
0.9%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
3,989
Price
$92.31
Total Value
$368.22K
Shares Held After
542,630
% of Holdings
0.7%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
2,638
Price
$91.49
Total Value
$241.35K
Shares Held After
546,619
% of Holdings
0.5%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
2,683
Price
$90.10
Total Value
$241.74K
Shares Held After
549,257
% of Holdings
0.5%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
600
Price
$89.14
Total Value
$53.48K
Shares Held After
551,940
% of Holdings
0.1%
Karyopharm Therapeutics Inc. (KPTI)
Abate Kristin — Chief Accounting Officer
Shares
378
Price
$1.19
Total Value
$449.82
Shares Held After
23,404
% of Holdings
1.6%
Oruka Therapeutics, Inc. (ORKA)
Klein Lawrence Otto — Director
Shares
200
Price
$84.78
Total Value
$16.96K
Shares Held After
923,128
% of Holdings
0.0%
Oruka Therapeutics, Inc. (ORKA)
Klein Lawrence Otto — Director
Shares
8,554
Price
$84.03
Total Value
$718.75K
Shares Held After
923,328
% of Holdings
0.9%
Oruka Therapeutics, Inc. (ORKA)
Klein Lawrence Otto — Director
Shares
16,246
Price
$83.40
Total Value
$1.35M
Shares Held After
931,882
% of Holdings
1.7%
Beam Therapeutics Inc. (BEAM)
Cavanagh Bethany J — SVP, Finance and Treasurer
Shares
187
Price
$24.41
Total Value
$4.56K
Shares Held After
50,984
% of Holdings
0.4%
Vaxcyte, Inc. (PCVX)
Wassil Jim — EVP, Chief Scientific Ofc, COO
Shares
95
Price
$57.09
Total Value
$5.42K
Shares Held After
145,435
% of Holdings
0.1%
Vaxcyte, Inc. (PCVX)
Wassil Jim — EVP, Chief Scientific Ofc, COO
Shares
2,155
Price
$56.65
Total Value
$122.09K
Shares Held After
145,530
% of Holdings
1.5%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D&CMO
Shares
16,141
Price
$26.93
Total Value
$434.74K
Shares Held After
0
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
31,908
Price
$27.02
Total Value
$862.19K
Shares Held After
191,447
% of Holdings
14.3%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
2,593
Price
$27.02
Total Value
$70.07K
Shares Held After
15,558
% of Holdings
14.3%
Orchestra BioMed Holdings, Inc. (OBIO)
Sherman Darren — Director
Shares
15,000
Price
$6.36
Total Value
$95.40K
Shares Held After
1,119,402
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$584.66
Total Value
$210.48K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$583.28
Total Value
$233.31K
Shares Held After
324,803
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$582.24
Total Value
$302.77K
Shares Held After
325,203
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
702
Price
$581.21
Total Value
$408.01K
Shares Held After
325,723
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
864
Price
$580.20
Total Value
$501.29K
Shares Held After
326,425
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$579.02
Total Value
$185.29K
Shares Held After
327,289
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
930
Price
$577.93
Total Value
$537.48K
Shares Held After
327,609
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
774
Price
$576.91
Total Value
$446.52K
Shares Held After
328,539
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,346
Price
$575.90
Total Value
$775.17K
Shares Held After
329,313
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
830
Price
$574.94
Total Value
$477.20K
Shares Held After
330,659
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$573.62
Total Value
$160.61K
Shares Held After
331,489
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$572.86
Total Value
$320.80K
Shares Held After
331,769
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$571.52
Total Value
$182.89K
Shares Held After
332,329
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
534
Price
$570.55
Total Value
$304.67K
Shares Held After
332,649
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
306
Price
$569.65
Total Value
$174.31K
Shares Held After
333,183
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
94
Price
$567.90
Total Value
$53.38K
Shares Held After
333,489
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$563.31
Total Value
$90.13K
Shares Held After
333,583
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$561.68
Total Value
$44.93K
Shares Held After
333,743
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$560.05
Total Value
$67.21K
Shares Held After
333,823
% of Holdings
0.0%
Showing 1–50 of 939 transactions (page 1 of 19)